Moylan Leads Effort to Control Cost of Insulin

DES PLAINES, Ill. – Working to lower the cost of lifesaving health care, state Rep. Marty Moylan, D–Des Plaines, recently backed legislation aimed at controlling the cost of insulin.

“The 1.3 million Illinoisans who require insulin to manage their diabetes shouldn’t have to decide between paying their bills and receiving the lifesaving health care they need,” Moylan said. “They all deserve to have the treatment they need to be readily available to them.”

The Moylan-supported Senate Bill 667 aims to address the high cost of insulin by limiting patients’ co-pays. The bill would set a cost ceiling at $100 per month, and is in response to insulin prices tripling between 2002 and 2013 according to a recent analysis. High costs have forced one in four diabetes patients to ration their insulin, according to the Yale School of Medicine.

“We simply cannot allow individuals to risk their personal health because they have to ration the insulin they can afford,” Moylan said. “This bill will help ease the financial burden so many people deal with so they can manage their condition and not worry about running out of their medication.”

For more information about this legislation please contact Moylan’s full-time constituent office at 847-635-6821 or email StateRepMoylan@gmail.com.